Bienaime Jean Jacques's Form 4 filing
Biomarin Pharmaceutical Inc (BMRN) · filed May 11, 2023
- Accession no.
- 0001209191-23-028813
- Filed
- May 11, 2023
- Trade date
- Apr 28-May 10, 2023
- Filing delay
- 13 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions and 2 derivative transactions. Open-market sales total $5.69M. It was filed 13 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bienaime Jean JacquesCIK 0001221590 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 28, 2023 | Common Stock | AGrant or awardAcquired | +317 | $66.88 | +$21,200.96 | 426,213 | Direct | |
| May 9, 2023 | Common Stock | MOption exerciseAcquired | +30,000 | $67.81 | +$2,034,300 | 456,213 | Direct | |
| May 9, 2023 | Common Stock | SSaleDisposed | −13,626 | $94.22 | −$1,283,841.72 | 442,587 | Direct | |
| May 9, 2023 | Common Stock | SSaleDisposed | −14,964 | $95.49 | −$1,428,912.36 | 427,623 | Direct | |
| May 9, 2023 | Common Stock | SSaleDisposed | −1,410 | $95.90 | −$135,219 | 426,213 | Direct | |
| May 10, 2023 | Common Stock | MOption exerciseAcquired | +30,000 | $67.81 | +$2,034,300 | 456,213 | Direct | |
| May 10, 2023 | Common Stock | SSaleDisposed | −21,453 | $94.65 | −$2,030,526.45 | 434,760 | Direct | |
| May 10, 2023 | Common Stock | SSaleDisposed | −8,547 | $95.34 | −$814,870.98 | 426,213 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 9, 2023 | Common Stock | MOption exerciseDisposed | −30,000 | $0.00 | $0 | 99,130 | Direct | |
| May 9, 2023 | Common Stock | MOption exerciseDisposed | −30,000 | $0.00 | $0 | 69,130 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.